Rebuffed suitor Stonebridge Healthcare tries once more to buy Tower Health
Under its proposal, Stonebridge would commit to hiring substantially all of Tower Health's hospital employees at pay levels "reasonably consistent" with rates paid by Tower. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 29, 2022 Category: Pharmaceuticals Authors: John George Source Type: news

Does Ethical AI Development Rely On The “Algorithmically” Underserved? CHAI’s Mission
Building this kind of standardization into the relatively black box nature of AI development is among the priorities of The Coalition for Health AI (CHAI), which launched earlier this year. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 29, 2022 Category: Pharmaceuticals Authors: Seth Joseph, Contributor Tags: Healthcare /healthcare Innovation /innovation AI /ai Source Type: news

Epidemic coalition sets out plan to develop future vaccines in 100 days
Cepi releases blueprint to move three times faster against a new virus than during Covid-19 pandemic (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - November 29, 2022 Category: Pharmaceuticals Source Type: news

Cerebral Palsy Risk Up With Exposure to Maternal Unintentional Injury In Utero
TUESDAY, Nov. 29, 2022 -- Exposure to maternal injury in utero is associated with increased risk of cerebral palsy (CP), according to a study published online Nov. 28 in JAMA Pediatrics. Asma Ahmed, M.D., Ph.D., M.P.H., from McGill University in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news

Risk of Uterine Diseases, Cancers Up With Tamoxifen Treatment
TUESDAY, Nov. 29, 2022 -- Tamoxifen treatment is associated with increased risk of endometrial hyperplasia, polyps, and carcinoma, as well as other uterine cancers, according to a study published online Nov. 28 in JAMA Network Open. Ki-Jin Ryu,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news

Melanoma Diagnosis Linked to Increased Risk of Prostate Cancer
TUESDAY, Nov. 29, 2022 -- Melanoma diagnosis is associated with increased risk of subsequent prostate cancer, according to a study published online Nov. 1 in the British Journal of Cancer. Sam Egger, from the University of Sydney, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news

Lower Frequency of Adding Salt to Food Linked to Lower CVD Risk
TUESDAY, Nov. 29, 2022 -- Lower frequency of adding salt to food is associated with reduced risk of cardiovascular disease (CVD), according to a study published in the Dec. 6 issue of the Journal of the American College of Cardiology. Hao Ma, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news

Mean Length of Preclinical Detectable Phase of Glaucoma & gt;10 Years
TUESDAY, Nov. 29, 2022 -- The mean length of the preclinical detectable phase (PCDP) of open-angle glaucoma is estimated to be over 10 years, according to a study published online Nov. 23 in JAMA Ophthalmology. Johan Aspberg, M.D., from Lund... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news

Combination Treatment Beneficial in Albuminuric CKD
TUESDAY, Nov. 29, 2022 -- For patients with albuminuric chronic kidney disease (CKD) without diabetes, treatment with the combination of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and sodium-glucose cotransporter-2... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news

The N Protein, A New Target For Anti-Covid Drugs
FDA-approved drug inhibits SARS-CoV-2 nucleocapsid phosphorylation and viral replication. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 29, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Twitter Stops Enforcing Covid-19 Misinformation Policy
The platform quietly stopped moderating pandemic misinformation last week, according to a message from the company. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 29, 2022 Category: Pharmaceuticals Authors: Carlie Porterfield, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus consumer Source Type: news

Left Digit Bias Seen in Acceptance of Organs for Donation
TUESDAY, Nov. 29, 2022 -- There is a significant left digit bias in the selection and acceptance of organs for donation, according to a study published in the October issue of the American Journal of Surgery. Clare E. Jacobson, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news

Antidepressants Have Small Benefit for Pain, Function in OA
TUESDAY, Nov. 29, 2022 -- Antidepressants lead to a small, but clinically unimportant, improvement in pain and function in patients with osteoarthritis, according to a review published online Oct. 21 in the Cochrane Library. Alexandra A. Leaney,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news

Geographic Distribution of Dimorphic Mycoses Expanding in U.S.
TUESDAY, Nov. 29, 2022 -- The geographic distribution of dimorphic mycoses (DM) is expanding in the United States, according to a study published online Nov. 11 in Clinical Infectious Diseases and an editorial published online Nov. 22 in the Annals... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news

Building Resilience In Healthcare: An Interview With Stephanie Vojicic, President Of Anthem Blue Cross And Blue Shield In Missouri
In the era of the Great Resignation, it seems rare to stay in one place for more than a few years. Vojicic, on the other hand, possesses tremendous institutional knowledge and great insight into the needs of the communities she serves through a decades-long commitment to advancing health. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 29, 2022 Category: Pharmaceuticals Authors: Deeptee Jain, Contributor Tags: ForbesWomen /forbeswomen Leadership /leadership Innovation /innovation Healthcare /healthcare Source Type: news